tiprankstipranks
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market
INBX
Inhibrx Biosciences Inc
RESEARCH TOOLSreports

Inhibrx Biosciences Inc (INBX) Financial Statements

59 Followers

Inhibrx Biosciences Inc Financial Overview

Inhibrx Biosciences Inc's market cap is currently $927.99M. The company's EPS TTM is $-2.11; its P/E ratio is ―; Inhibrx Biosciences Inc is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-1.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.30M$ 200.00K$ 1.80M$ 2.19M$ 7.13M
Gross Profit$ -1.18M$ -2.08M$ 609.00K$ -107.99M$ 4.44M
Operating Income$ -135.03M$ -331.45M$ -219.22M$ -129.12M$ -76.56M
EBITDA$ -132.54M$ 1.70B$ -206.69M$ -125.82M$ -75.37M
Net Income$ -140.06M$ 1.69B$ -241.36M$ -145.23M$ -81.77M
Balance Sheet
Cash & Short-Term Investments$ 124.22M$ 152.60M$ 277.92M$ 273.87M$ 131.30M
Total Assets$ 146.48M$ 180.77M$ 307.89M$ 290.88M$ 150.45M
Total Debt$ 107.01M$ 8.05M$ 210.14M$ 207.10M$ 72.14M
Net Debt$ -17.21M$ -144.55M$ -67.78M$ -66.76M$ -59.16M
Total Liabilities$ 138.49M$ 47.18M$ 264.39M$ 232.82M$ 98.07M
Stockholders' Equity$ 7.99M$ 133.58M$ 43.50M$ 58.06M$ 52.38M
Cash Flow
Free Cash Flow$ -129.82M$ -197.01M$ -197.90M$ -115.99M$ -81.19M
Operating Cash Flow$ -129.79M$ -194.41M$ -193.31M$ -115.30M$ -80.32M
Investing Cash Flow$ -28.00K$ -2.60M$ -4.59M$ -686.00K$ -809.00K
Financing Cash Flow$ 101.45M$ 71.68M$ 201.96M$ 258.55M$ 83.77M
Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History

Income Statement >

Inhibrx Biosciences Inc Debt to Assets

Balance Sheet >

Inhibrx Biosciences Inc Cash Flow

Cash Flow >

Inhibrx Biosciences Inc Forecast EPS vs Actual EPS

Earnings >